ID23306A - Turunan-turunan di- atau triaza-spiro dekana - Google Patents

Turunan-turunan di- atau triaza-spiro dekana

Info

Publication number
ID23306A
ID23306A IDP990575D ID990575D ID23306A ID 23306 A ID23306 A ID 23306A ID P990575 D IDP990575 D ID P990575D ID 990575 D ID990575 D ID 990575D ID 23306 A ID23306 A ID 23306A
Authority
ID
Indonesia
Prior art keywords
tranza
depana
deman
duran
duran tranza
Prior art date
Application number
IDP990575D
Other languages
English (en)
Inventor
Geo Adam
Andrea Cesura
Francois Jenck
Sabine Kolczewski
Stephan Rover
Jurgen Wichmann
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ID23306A publication Critical patent/ID23306A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/10—Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDP990575D 1998-06-12 1999-06-14 Turunan-turunan di- atau triaza-spiro dekana ID23306A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98110803 1998-06-12

Publications (1)

Publication Number Publication Date
ID23306A true ID23306A (id) 2000-04-05

Family

ID=8232113

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP990575D ID23306A (id) 1998-06-12 1999-06-14 Turunan-turunan di- atau triaza-spiro dekana

Country Status (30)

Country Link
US (1) US6642247B2 (id)
EP (1) EP0963985B1 (id)
JP (1) JP3369123B2 (id)
KR (1) KR100393311B1 (id)
CN (2) CN1110497C (id)
AR (1) AR019860A1 (id)
AT (1) ATE234302T1 (id)
AU (1) AU752835B2 (id)
BR (1) BR9902653A (id)
CA (1) CA2274201C (id)
CO (1) CO5040061A1 (id)
CZ (1) CZ291323B6 (id)
DE (1) DE69905798T2 (id)
DK (1) DK0963985T3 (id)
ES (1) ES2194402T3 (id)
HR (1) HRP990187A2 (id)
HU (1) HUP9901910A3 (id)
ID (1) ID23306A (id)
IL (1) IL130375A0 (id)
MA (1) MA26645A1 (id)
NO (1) NO312591B1 (id)
NZ (1) NZ336226A (id)
PE (1) PE20000540A1 (id)
PL (1) PL333693A1 (id)
PT (1) PT963985E (id)
SG (1) SG83135A1 (id)
TR (1) TR199901380A2 (id)
TW (1) TW434241B (id)
YU (1) YU26799A (id)
ZA (2) ZA993853B (id)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0997464B1 (en) * 1998-10-23 2005-02-16 Pfizer Inc. 1,3,8-Triazaspiro[4,5] decanone compounds as orl1-receptor agonists
PT1491212E (pt) 2002-03-29 2012-11-16 Mitsubishi Tanabe Pharma Corp Medicamento para distúrbios de sono
DE102004014296A1 (de) 2004-03-22 2005-10-06 Grünenthal GmbH Substituierte 1,4,8-Triazaspiro[4.5]decan-2-on-Verbindingen
KR100662191B1 (ko) 2004-12-23 2006-12-27 엘지이노텍 주식회사 질화물 반도체 발광소자 및 그 제조방법
MX2009009355A (es) 2007-03-01 2009-09-11 Mitsubishi Tanabe Pharma Corp Compuesto de bencimidazol y uso farmaceutico del mismo.
TW201016675A (en) 2008-09-16 2010-05-01 Mitsubishi Tanabe Pharma Corp Crystalline benzoimidazole compound and salt thereof
CN109503582A (zh) * 2018-12-17 2019-03-22 上海合全药物研发有限公司 顺式螺[哌啶并-4,1＇-吡咯并[3,4-c]吡咯]-1-甲酸叔丁酯的合成方法
AU2021270664B2 (en) * 2020-05-12 2024-05-30 Beijing Greatway Pharmaceutical Technology Co., Ltd. Compound for adjusting activity of NMDA receptor, and pharmaceutical composition and use thereof
KR20220022988A (ko) 2020-08-20 2022-03-02 제트스타 주식회사 트랙터용 써레

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63208844A (ja) * 1987-02-26 1988-08-30 Konica Corp 有機着色物質の光褪色防止方法
US5221675A (en) * 1989-12-15 1993-06-22 Abbott Laboratories Aza-spirocyclic compounds that enhance cholinergic neurotransmission
US5534520A (en) * 1990-04-10 1996-07-09 Fisher; Abraham Spiro compounds containing five-membered rings
CA2226058C (en) * 1997-01-30 2008-01-29 F. Hoffmann-La Roche Ag 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives

Also Published As

Publication number Publication date
NZ336226A (en) 2000-10-27
HUP9901910A2 (hu) 2000-04-28
JP2000026466A (ja) 2000-01-25
CZ203999A3 (cs) 2000-03-15
EP0963985B1 (en) 2003-03-12
CN1229377C (zh) 2005-11-30
DE69905798T2 (de) 2004-02-12
DK0963985T3 (da) 2003-06-23
CZ291323B6 (cs) 2003-02-12
KR20000006135A (ko) 2000-01-25
EP0963985A2 (en) 1999-12-15
JP3369123B2 (ja) 2003-01-20
US20030176701A1 (en) 2003-09-18
KR100393311B1 (ko) 2003-08-02
HUP9901910A3 (en) 2001-11-28
PT963985E (pt) 2003-06-30
NO992876L (no) 1999-12-13
ATE234302T1 (de) 2003-03-15
CN1242367A (zh) 2000-01-26
ES2194402T3 (es) 2003-11-16
TR199901380A3 (tr) 2001-01-22
DE69905798D1 (de) 2003-04-17
HRP990187A2 (en) 2000-02-29
CA2274201A1 (en) 1999-12-12
HU9901910D0 (en) 1999-08-30
PL333693A1 (en) 1999-12-20
NO312591B1 (no) 2002-06-03
NO992876D0 (no) 1999-06-11
CO5040061A1 (es) 2001-05-29
AR019860A1 (es) 2002-03-20
US6642247B2 (en) 2003-11-04
PE20000540A1 (es) 2000-07-15
ZA993853B (en) 1999-12-13
CA2274201C (en) 2010-02-09
IL130375A0 (en) 2000-06-01
CN1244528A (zh) 2000-02-16
TR199901380A2 (xx) 2001-01-22
CN1110497C (zh) 2003-06-04
YU26799A (sh) 2002-03-18
MA26645A1 (fr) 2004-12-20
BR9902653A (pt) 2000-05-02
SG83135A1 (en) 2001-09-18
EP0963985A3 (en) 2001-01-24
TW434241B (en) 2001-05-16
AU3498699A (en) 1999-12-23
ZA993901B (en) 1999-12-13
AU752835B2 (en) 2002-10-03

Similar Documents

Publication Publication Date Title
DE69937850D1 (de) Hautablationslaser
DE69926979D1 (de) Leitschaufelbefestigung
DE69908817D1 (de) Laderaum
DE69808145D1 (de) Tintenbehälternachfüllsystem
DE59902874D1 (de) Buchsenkontakt
DE69904565D1 (de) Hubventilsteuerungseinrichtung
DE69921320D1 (de) Turbinenstatorschaufel
DE69922126D1 (de) Abwickelführungsrohr
DE69812868D1 (de) Flanschreformierungsanlage
DE69928148D1 (de) Wasserskimmer
DE69919631D1 (de) Isoliermembranmontage
DE69910986D1 (de) Atmosphärenteilchenanalysator
DE69939653D1 (de) Erkstoff
ATE262513T1 (de) Benzoylpyridazine
DE69919644D1 (de) Wellenabstreifdichtung
DE59908769D1 (de) N-arylsulfonyl-aminosäure-omega-amide
DE69820261D1 (de) Steuerventilanordnnung
DE69936434D1 (de) Bildverabeitungsvorrichtung
DE59903106D1 (de) Tripode-gleichlaufdrehgelenk
FI980251A0 (fi) Breddstraeckvals
DE69809804D1 (de) Notlaufgeländereifen
EA199900675A3 (ru) Полиморф моногидрата зополрестата
DE69935559D1 (de) Bussignalleitungstreiber
DE69918165D1 (de) Doramectinformulierungen
DE59900612D1 (de) Dispersionsazofarbstoffmischungen